The AML variant characterized by mutation in the NMP1 (nucleophosmin) gene shows a frequent high expression of Versican, which is believed to be associated with the pathogenesis and clinical course of the disease [98]. The gene discussed is NPM1; the disease is acute myeloid leukemia.